Percheron Therapeutics Ltd logo

Percheron Therapeutics Ltd

NEW
ASX:PER (Australia)  
A$ 0.0035 (0%) Jul 2
At Loss
P/B:
0.58
Market Cap:
A$ 5.33M ($ 3.67M)
Enterprise V:
A$ 883.00K ($ 609.00K)
Volume:
572.84K
Avg Vol (2M):
3.81M
Trade In:
Volume:
572.84K
At Loss
Avg Vol (2M):
3.81M

Percheron Therapeutics Ltd (ASX:PER) Dividend

Percheron Therapeutics Ltd (ASX:PER) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -17.6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ASX:PER Dividend

Does Percheron Therapeutics Ltd (ASX:PER) pay a dividend?

Percheron Therapeutics Ltd (ASX:PER) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Percheron Therapeutics Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Percheron Therapeutics Ltd has returned capital to shareholders via buybacks at a rate of -17.6% over the past 3 years.

What are dividend-paying alternatives to Percheron Therapeutics Ltd?

For dividend-paying alternatives in Percheron Therapeutics Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.